- 2 updates
A review last year by NHS medical director, Professor Sir Bruce Keogh, concluded the PIP breast implants were not toxic or carcinogenic.
Today's European study said the implants have not been associated with higher risks of cancer.
It added: "Laboratory tests on PIP implants have been negative for cytotoxicity and genotoxicity."
The study said PIP implants have been subjected to chemical analysis "in an effort to find organic and inorganic compounds (including heavy metals) that may be potentially toxic, but none have been found even at very low levels".
European regulators have concluded that there is no evidence that women who have PIP breast implants are at higher risk of cancer.
Women also do not need to have the faulty implants removed as a precaution although they may wish to have them taken out if they feel anxious, according to a review of PIP safety published by the European Commission's Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR).
Around 47,000 British women are thought to have been given the implants manufactured by the closed French company Poly Implant Prothese (PIP).